Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of In-House Developed Nanomedicine Technology for Diagnosis and Management of Post-Transplant Heart Allograft Patients

NCT01929785 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT01929785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01929785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of In-House Developed Nanomedicine Technology for Diagnosis and Management of Post-Transplant Heart Allograft Patients
Lead sponsor
Baylor Research Institute
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
November 30, 2013
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplant failure